Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Region-selective permeability of the blood-brain barrier to α-aminoisobutyric acid during thiamine deficiency and following its reversal.

Metabolic brain disease·2020
Same author

Potential for stem cell treatment in manganism.

Neurochemistry international·2017
Same author

Acute liver failure is associated with altered cerebral expression profiles of long non-coding RNAs.

Neuroscience letters·2017
Same author

Treatment of rats with the JAK-2 inhibitor fedratinib does not lead to experimental Wernicke's encephalopathy.

Neuroscience letters·2017
Same author

The Vegetative State and Stem Cells: Therapeutic Considerations.

Frontiers in neurology·2016
Same author

Erratum to: Acute liver failure-induced hepatic encephalopathy is associated with changes in microRNA expression profiles in cerebral cortex of the mouse.

Metabolic brain disease·2014

Related Experiment Video

Updated: Jun 26, 2025

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
09:29

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells

Published on: July 10, 2019

10.8K

Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage.

Alan S Hazell1

  • 1Department of Medicine, University of Montreal, 2335 Bennett Avenue, Montreal, QC, H1V 2T6, Canada. ashneuro@dr.com.

Neurochemical Research
|May 8, 2024
PubMed
Summary

Stem cell therapy shows promise for treating Wernicke

Keywords:
ExcitotoxicityNeurodegenerationOxidative Stress, NeurogenesisThiamine deficiencyVitamin B1Wernicke’s encephalopathyblood-brain Barrierstem cell

More Related Videos

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.9K
Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
06:12

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

3.1K

Related Experiment Videos

Last Updated: Jun 26, 2025

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
09:29

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells

Published on: July 10, 2019

10.8K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.9K
Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
06:12

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

3.1K

Area of Science:

  • Neuroscience
  • Regenerative Medicine

Background:

  • Wernicke's encephalopathy (WE) is a severe central nervous system disorder caused by thiamine deficiency (TD).
  • TD leads to significant brain damage, particularly in the thalamus and inferior colliculus, with limited effective treatments for resulting cognitive impairments.
  • Current therapeutic strategies for established brain lesions in WE remain largely ineffective.

Purpose of the Study:

  • To explore the potential of stem cell treatment as a therapeutic strategy for Wernicke's encephalopathy.
  • To review the effects of thiamine deficiency on brain integrity and associated consequences.
  • To discuss the future benefits and challenges of utilizing stem cells for WE treatment.

Main Methods:

  • Review of existing research on the pathophysiology of thiamine deficiency and brain damage.
  • Examination of stem cell capabilities in repairing neural damage and improving function.
  • Analysis of pathophysiological similarities between WE and other neurodegenerative diseases treatable by stem cells.

Main Results:

  • Thiamine deficiency causes critical damage to brain regions, leading to persistent cognitive deficits.
  • Stem cells possess inherent properties for tissue repair and functional restoration in the nervous system.
  • Stem cell therapy offers a potential avenue for treating neurodegenerative conditions with overlapping features with WE.

Conclusions:

  • Stem cell therapy presents a promising, novel therapeutic strategy for Wernicke's encephalopathy.
  • Further research is needed to overcome obstacles and establish stem cell treatment viability for human patients.
  • Addressing the neurodegenerative aspects of WE through stem cells could revolutionize patient outcomes.